Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who have completed 12 weeks of treatment in the double blind trial PATENT 1
You may not be if
Patients who have an ongoing serious adverse event from PATENT 1 that is assessed as related to BAY63-2521 are not allowed to participate in the extension trial.
